TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/26/2024
Back to search
Official data from USPTO
DOMPE' X THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DOMPE' X THERAPEUTICS
ST13
US500000079347038Class
5, 9, 42
Filing
79347038
Registration
7185195
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
12/31/2024
Trademark type
Word
Nice classes
5, 9, 42
Filing date
04/12/2022
Registration date
10/10/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/10/2023
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
IT
Examiner
YOO, JEANE
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DOMPE' FARMACEUTICI S.P.A.
Representatives
Theodore R. Remaklus Thompson Hine LLP
Technical classification
Nice Classes
Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of eye diseasesof painof febrile states and influenzaof muscle diseasesof diabetesof the consequences of organ transplantsof tumorsof gastrointestinal diseases; disinfectants for hygiene
Class 9
Downloadable computer software for use in the identification of new drugs also using artificial intelligence; downloadable computer software for use by doctors and other medical professionals to acquiretrackreportanalyse health data for use in making informed medical decisions; downloadable virtual reality software for medical teaching; downloadable virtual reality software for medical screening; downloadable computer software platforms for use in database management in the field of medicine; downloadable application software for mobile phonessoftware for use in the identification of new drugs
Class 42
Software as a service (SAAS) services with software using artificial intelligence for the identification of new drugs; provision of on-line non-downloadable software using artificial intelligence for use in the identification of new drugs via a website; research in the field of artificial intelligence; design and development of computer software in the field of medicine; design and development of virtual reality software for medical screening; design and development of software for medical education
Publications
History of USPTO decisions and trademark events.
30 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/26/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/26/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/26/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/26/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/06/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/14/2024
FIMP
FINAL DISPOSITION PROCESSED
01/13/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/25/2023
PUBO
PUBLISHED FOR OPPOSITION
07/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/22/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/21/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/21/2023
RFNT
REFUSAL PROCESSED BY IB
03/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/14/2023
RFRR
REFUSAL PROCESSED BY MPU
02/14/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/11/2023
CNRT
NON-FINAL ACTION WRITTEN
02/10/2023
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
02/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/04/2023
CNRT
NON-FINAL ACTION WRITTEN
02/03/2023
DOCK
ASSIGNED TO EXAMINER
01/30/2023
MAFR
APPLICATION FILING RECEIPT MAILED
08/16/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/11/2022
Continuous trademark protection
Get notified about every new filing that threatens DOMPE' X THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.